DURHAM, NC– – Aldagen, Inc. today announced that a poster describing the homing properties of its cellular therapies was presented at the Seventh International Conference on Cell Therapy for Cardiovascular …
See the original post here:
Aldagen Presents Data Describing Cell Therapy Products' Mechanism for Homing to Ischemic Injury